Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Could Chili Peppers Be The Answer To Opioid-Reliance For Chronic Pain?
Chinese Expats Revolutionizing China's Homegrown Biopharma Sector
Pfizer's cholesterol fighter bococizumab successful in two more late-stage studies (Seeking Alpha)
Related GRMN
Fitbit Ripe For Takeover With Samsung And Apple's Commitment To Wearables
Garmin Increases Position In Wearables Market With Device, Community And Third-Party App Tactics

Analysts at Deutsche Bank initiated coverage on Pfizer (NYSE: PFE) with a Buy rating. The target price for Pfizer is set to $34. Pfizer's shares closed at $29.21 yesterday.

Baird initiated coverage on shares of Garmin (NASDAQ: GRMN) with a Neutral rating. The target price for Garmin is set to $59. Garmin's shares closed at $57.46 yesterday.

Analysts at DA Davidson initiated coverage on shares of Oracle (NASDAQ: ORCL) with a Neutral rating. The target price for Oracle is set to $46. Oracle's shares closed at $41.84 yesterday.

Analysts at Jefferies initiated coverage on MannKind (NASDAQ: MNKD) with a Buy rating. The target price for MannKind is set to $10. MannKind's shares closed at $7.34 yesterday.

Latest Ratings for PFE

DateFirmActionFromTo
Jun 2016JefferiesMaintainsBuy
Jun 2016JefferiesMaintainsBuy
May 2016BerenbergInitiates Coverage onHold

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (GRMN + MNKD)

View Comments and Join the Discussion!